December 01, 2020 Feature

Compulsory Patent Licensing in the Time of COVID-19: Views from the United States, Canada, and Europe

Abbas Kassam, Matt Norwood, Ute Pfaller, Charles F. Hauff Jr., and Jeffrey D. Morton

©2020. Published in Landslide, Vol. 13, No. 2, November/December 2020, by the American Bar Association. Reproduced with permission. All rights reserved. This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association or the copyright holder.

The COVID-19 pandemic that has impacted the world over the past half year has raised a myriad of legal questions in all aspects of our daily lives. The eventual development of a suitable vaccine, which will likely be the subject of patent protection in the U.S. and abroad, has run into a theoretical conflict with the possibility that the supply of the vaccine might be unable to keep up with the demand.

Premium Content For:
  • Intellectual Property Law Section
Join - Now